What is NDC 72266-257?

72266-257 is the product NDC for Guanfacine, Guanfacine hydrochloride 3 mg/1 tablet, extended release, listed with the FDA by Fosun Pharma USA, Inc. It has 1 package NDC, shown above in 10- and 11-digit form.

Fosun Pharma USA, Inc, NDC labeler code 72266. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Guanfacine?

71 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Guanfacine NDC 72266-257 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)72266-257Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72266-0257Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72266-257-55	7226602575572266025755	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72266-257-55)Marketed from Oct 1, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Guanfacine
Generic name (nonproprietary): guanfacine
Active ingredients: Guanfacine hydrochloride — 3 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Fosun Pharma USA, IncNDC labeler code 72266
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217638
Marketing start: Oct 1, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic alpha2-Agonists (Mechanism)
Identifiers: Product ID 72266-257_53ff602c-4688-bace-e063-6394a90a2ffdSPL ID 53ff602c-4688-bace-e063-6394a90a2ffdSPL set ID 261c06ce-8708-d659-e063-6294a90ac381RxCUI 862006, 862013, 862019, 862025UNII PML56A160O
Pharmacologic class: Central alpha-2 Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472266025755 followed by a unit qualifier and the quantity

Package 72266-0257-55. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 4, 2024.

Indications (excerpt from the label)

Guanfacine extended-release tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications [see Clinical Studies (14) ] . Guanfacine extended-release tablets are central alpha 2A -adrenergic receptor agonist indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications ( 1 , 14 ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 72266-257

What is NDC 72266-257?: 72266-257 is the product NDC for Guanfacine, Guanfacine hydrochloride 3 mg/1 tablet, extended release, listed with the FDA by Fosun Pharma USA, Inc. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Guanfacine.
What is the active ingredient?: Guanfacine hydrochloride.
Who is the labeler?: Fosun Pharma USA, Inc, NDC labeler code 72266. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Guanfacine?: 71 other product NDCs are listed under this name. See all Guanfacine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Guanfacine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Guanfacine	Guanfacine hydrochloride 2 mg/1	Tablet, Extended releaseOral	REMEDYREPACK INC.	70518-4675	70518-4675-00
Guanfacine	Guanfacine hydrochloride 4 mg/1	Tablet, Extended releaseOral	Fosun Pharma USA, Inc	72266-258	72266-0258-55
Guanfacinegaunfacine	Guanfacine hydrochloride 2 mg/1	TabletOral	REMEDYREPACK INC.	70518-4564	70518-4564-00
Guanfacine	Guanfacine hydrochloride 2 mg/1	TabletOral	Coupler LLC	67046-1655	67046-1655-03
Guanfacine	Guanfacine hydrochloride 1 mg/1	Tablet, Extended releaseOral	REMEDYREPACK INC.	70518-4539	70518-4539-00
Guanfacine	Guanfacine hydrochloride 1 mg/1	Tablet, Extended releaseOral	Fosun Pharma USA, Inc	72266-255	72266-0255-55
Guanfacine	Guanfacine hydrochloride 2 mg/1	Tablet, Extended releaseOral	Fosun Pharma USA, Inc	72266-256	72266-0256-55
Guanfacine	Guanfacine hydrochloride 2 mg/1	TabletOral	REMEDYREPACK INC.	70518-4488	70518-4488-00
Guanfacine	Guanfacine hydrochloride 1 mg/1	Tablet, Extended releaseOral	St. Mary's Medical Park Pharmacy	60760-863	60760-0863-30
Guanfacine	Guanfacine hydrochloride 1 mg/1	TabletOral	REMEDYREPACK INC.	70518-4333	70518-4333-00

All 72 Guanfacine NDCs

Other NDCs under ANDA 217638

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217638
Product	Strength	Form · route	Labeler	Product NDC
Guanfacine	Guanfacine hydrochloride 1 mg/1	Tablet, Extended releaseOral	Fosun Pharma USA, Inc	72266-255
Guanfacine	Guanfacine hydrochloride 2 mg/1	Tablet, Extended releaseOral	Fosun Pharma USA, Inc	72266-256
Guanfacine	Guanfacine hydrochloride 4 mg/1	Tablet, Extended releaseOral	Fosun Pharma USA, Inc	72266-258